UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system

BMC cancer, 2022-05, Vol.22 (1), p.593-593, Article 593

2022

Volltextzugriff (PDF)

Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer

Cancer biology & therapy, 2007-11, Vol.6 (11), p.1691-1699

2007

Volltextzugriff (PDF)

PP01.93 RET fusion as a treatable resistance mechanism in EGFR mutation lung cancer - A case report

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e41-e41

2024

Volltextzugriff (PDF)

Abstract P3-14-16: Prevalence of low estrogen receptor and low progesterone receptor positivity at an urban safety net hospital

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-14-16

2022

Volltextzugriff (PDF)

Abstract PO-189: Racial disparities in attainment of pathological complete responses in HER2 positive breast cancer

Cancer epidemiology, biomarkers & prevention, 2022-01, Vol.31 (1_Supplement), p.PO-189-PO-189

2022

Volltextzugriff (PDF)

Outcomes of Patients With Acute Lymphoblastic Leukemia Treated at a Safety-Net Hospital

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S163-S163

2024

Volltextzugriff (PDF)

ALL-730 Outcomes of Patients With Acute Lymphoblastic Leukemia Treated at a Safety-Net Hospital

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S281-S282

2024

Volltextzugriff (PDF)

Optimizing Outpatient Referral Pattern for Monoclonal Gammopathy at a Safety-Net Hospital

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S246-S246

2024

Volltextzugriff (PDF)

MM-736 Optimizing Outpatient Referral Pattern for Monoclonal Gammopathy at a Safety-Net Hospital

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S581-S581

2024

Volltextzugriff (PDF)

PP01.137 Survival of Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC) Diagnosed at a Safety-Net Hospital (SNH)

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e59-e60

2024

Volltextzugriff (PDF)

PP01.40 Treatment Patterns and Survival Outcomes of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Survival at a Safety-Net Hospital

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e22-e22

2024

Volltextzugriff (PDF)

Abstract B032: Outcomes of patients with acute promyelocytic leukemia treated at John Peter Smith Hospital

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12_Supplement), p.B032-B032

2023

Volltextzugriff (PDF)

Time to treatment for lung cancer patients at an urban safety net institution

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.26-26

2019

Volltextzugriff (PDF)

Poster: AML-343 Outcomes of Patients With Acute Myeloid Leukemia Treated at a Safety-Net Hospital

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S134

2022

Volltextzugriff (PDF)

AML-343 Outcomes of Patients With Acute Myeloid Leukemia Treated at a Safety-Net Hospital

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S240

2022

Volltextzugriff (PDF)

Overall survival following implementation of clinical pathways for cancer care

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.328-328

2021

Volltextzugriff (PDF)

Comparative effectiveness of treatment approaches for early invasive breast cancer

Annals of epidemiology, 2024-08, Vol.96, p.66-72

2024

Volltextzugriff (PDF)

Patient-reported physical and mental health of socioeconomically disadvantaged cancer patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19041-e19041

2020

Volltextzugriff (PDF)

Prognostication based on TNM staging for socioeconomically disadvantaged colorectal cancer patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19036-e19036

2020

Volltextzugriff (PDF)

Abstract B033: Patterns of testing and survival for EGFR mutation and ALK abnormalities in advanced lung cancer at John Peter Smith Hospital

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12_Supplement), p.B033-B033

2023

Volltextzugriff (PDF)

Timing of adjuvant chemotherapy initiation and colon cancer survival

Journal of clinical oncology, 2019-11, Vol.37 (31_suppl), p.119-119

2019

Volltextzugriff (PDF)

Abstract 3056: Characteristics and outcomes of patients with hepatocellular carcinoma diagnosed at John Peter Smith Hospital

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3056-3056

2023

Volltextzugriff (PDF)

Abstract P5-14-21: Cardiotoxicity among socioeconomically disadvantaged breast cancer patients

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-14-21

2022

Volltextzugriff (PDF)

Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients

Annals of epidemiology, 2022-01, Vol.65, p.31-37

2022

Volltextzugriff (PDF)

Current Perspectives in Immunotherapy for Liver Cancer

Critical reviews in oncogenesis, 2020, Vol.25 (1), p.31-46

2020

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Oncology
(7)
Adult
(6)
Female
(5)
Middle Aged
(5)
Safety-Net
(5)
Aged
(4)
Breast Cancer
(4)
Cancer
(4)
Cancer Therapies
(3)
Care And Treatment
(3)
Chemotherapy
(3)
Health Aspects
(3)
Male
(3)
Patients
(3)
Proteins
(3)
Public, Environmental & Occupational Health
(3)
Survival
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system

Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer

PP01.93 RET fusion as a treatable resistance mechanism in EGFR mutation lung cancer - A case report

Abstract P3-14-16: Prevalence of low estrogen receptor and low progesterone receptor positivity at an urban safety net hospital

Abstract PO-189: Racial disparities in attainment of pathological complete responses in HER2 positive breast cancer

Outcomes of Patients With Acute Lymphoblastic Leukemia Treated at a Safety-Net Hospital

ALL-730 Outcomes of Patients With Acute Lymphoblastic Leukemia Treated at a Safety-Net Hospital

Optimizing Outpatient Referral Pattern for Monoclonal Gammopathy at a Safety-Net Hospital

MM-736 Optimizing Outpatient Referral Pattern for Monoclonal Gammopathy at a Safety-Net Hospital

PP01.137 Survival of Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC) Diagnosed at a Safety-Net Hospital (SNH)

PP01.40 Treatment Patterns and Survival Outcomes of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Survival at a Safety-Net Hospital

Abstract B032: Outcomes of patients with acute promyelocytic leukemia treated at John Peter Smith Hospital

Time to treatment for lung cancer patients at an urban safety net institution

Poster: AML-343 Outcomes of Patients With Acute Myeloid Leukemia Treated at a Safety-Net Hospital

AML-343 Outcomes of Patients With Acute Myeloid Leukemia Treated at a Safety-Net Hospital

Overall survival following implementation of clinical pathways for cancer care

Comparative effectiveness of treatment approaches for early invasive breast cancer

Patient-reported physical and mental health of socioeconomically disadvantaged cancer patients

Prognostication based on TNM staging for socioeconomically disadvantaged colorectal cancer patients

Abstract B033: Patterns of testing and survival for EGFR mutation and ALK abnormalities in advanced lung cancer at John Peter Smith Hospital

Timing of adjuvant chemotherapy initiation and colon cancer survival

Abstract 3056: Characteristics and outcomes of patients with hepatocellular carcinoma diagnosed at John Peter Smith Hospital

Abstract P5-14-21: Cardiotoxicity among socioeconomically disadvantaged breast cancer patients

Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients

Current Perspectives in Immunotherapy for Liver Cancer

Suchergebnisse filtern